thiazoles has been researched along with mdl 100907 in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abekawa, T; Honda, M; Ito, K; Koyama, T | 1 |
Adell, A; Amargós-Bosch, M; Artigas, F; Bortolozzi, A; Díaz-Mataix, L; Pons, S; Serrats, J | 1 |
Frecska, E; Gaszner, G; Keresztes, M | 1 |
Campbell, L; Cato, KJ; Clarke, K; Davies, CH; Gordon, L; Gribble, A; Heath, J; Jones, DN; Patel, N; Riley, G; Scott, C; Wood, MD; Worby, A | 1 |
Altschuler, EL; Focosi, D; Kast, RE; Petrini, M | 1 |
Ishibashi, T; Ishiyama, T; Ito, A; Ohno, Y; Tokuda, K; Toma, S | 1 |
Ice, K; Loebel, A; Lombardo, I; Warrington, L | 1 |
Papakostas, GI; Shelton, RC | 1 |
Aznar, S; El-Sayed, M; Elvang, AB; Ettrup, A; Holm, P; Klein, AB; Knudsen, GM; Mikkelsen, JD; Santini, MA; Stensbøl, TB | 1 |
Citrome, L | 1 |
Huang, M; Kwon, S; Meltzer, HY; Oyamada, Y; Panos, JJ; Rajagopal, L | 1 |
3 review(s) available for thiazoles and mdl 100907
Article | Year |
---|---|
Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome | 2007 |
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.
Topics: Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Disorders of Excessive Somnolence; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Isoindoles; Lurasidone Hydrochloride; Randomized Controlled Trials as Topic; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome; United States; United States Food and Drug Administration; Weight Gain | 2011 |
8 other study(ies) available for thiazoles and mdl 100907
Article | Year |
---|---|
Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Chromatography, High Pressure Liquid; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Haloperidol; Male; Microdialysis; Motor Activity; Phencyclidine; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D4; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stereotyped Behavior; Thiazoles; Time Factors | 2003 |
In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aminopyridines; Anesthetics, Local; Animals; Antipsychotic Agents; Benzopyrans; Blotting, Western; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Immunohistochemistry; In Situ Hybridization; Indoles; Indophenol; Male; Mice; Mice, Inbred C57BL; Microdialysis; Piperidines; Prazosin; Prefrontal Cortex; Quinoxalines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tetrodotoxin; Thiazoles; Time Factors | 2003 |
[Misdiagnosed PTSD and zeldox pharmacotherapy in case of a political prisoner].
Topics: Antipsychotic Agents; Communism; Diagnostic Errors; Humans; Hungary; Male; Middle Aged; Piperazines; Prisoners; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Stress Disorders, Post-Traumatic; Thiazoles | 2004 |
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Biogenic Monoamines; CHO Cells; Clozapine; Cricetinae; Dibenzothiazepines; Dopamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Thiazoles | 2006 |
Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.
Topics: Adult; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Piperazines; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Thiazoles | 2007 |
Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Isoindoles; Lurasidone Hydrochloride; Male; Memory; Rats; Rats, Wistar; Reaction Time; Serotonin 5-HT2 Receptor Antagonists; Thiazoles | 2007 |
Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.
Topics: Aging; Amphetamines; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Citalopram; Data Interpretation, Statistical; Fluorobenzenes; Genes, fos; Head Movements; Humans; In Situ Hybridization; Indicators and Reagents; Male; Mice; Mice, Transgenic; Piperidines; Plaque, Amyloid; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2010 |
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Cerebral Cortex; Dopamine; Glutamic Acid; Hippocampus; Isoindoles; Lurasidone Hydrochloride; Male; Microdialysis; Neurotransmitter Agents; Nucleus Accumbens; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Synaptic Transmission; Thiazoles | 2014 |